Venture Capital Media Coverage & News

Current News

01-12-2010	Sonnenschein Expands Life Sciences Practice with Addition of Ira Kotel as Partner in Venture Technology Group Ira Kotel’s practice focuses on the biotechnology sector and includes all major transactional areas.
12-02-2009	Sonnenschein Adds Eli Curi as Partner in New York Corporate Practice Curi’s work encompasses all major transactional areas, including mergers and acquisitions, private equity, venture capital and hedge funds.
11-18-2009	Victor Boyajian Quoted in AlwaysOn VC 100 List Honoring Top Venture Capitalists
10-02-2009	Sonnenschein Hosts Screening Day for Elite Entrepreneur Program in Silicon Valley 26 women-led start-ups presented to an audience of over 50 investors, CEOs and industry experts to qualify for the 8th Annual Astia Doing it Right program in Silicon Valley.
09-11-2009	Sonnenschein Selected to Represent Specialty Pharmaceutical Company Sonnenschein has been selected to represent Stymark, a development-stage specialty medical company.
07-08-2009	Randy Sabett Speaks on PBS About Cyber Attacks Against the U.S. Government Sonnenschein partner Randy Sabett appears on "NewsHour with Jim Lehrer" on July 8.
06-17-2009	Sonnenschein Advises Paymo in Acquisition by Boku
04-20-2009	Sonnenschein Continues Growth in Silicon Valley with Addition of International Venture Lawyer Daniel Zimmermann's practice focuses on the representation of significant, high quality U.S.-based technology companies with U.S. venture backing and key international business, as well as foreign issuers with inbound U.S. business.
04-07-2009	Victor Boyajian Quoted on Venture Firms and Stimulus Funds The Wall Street Journal April 7 "Digits" blog post, "Silicon Valley Goes from Libertarian to Keynesian."
03-31-2009	Sonnenschein's Venture Technology Group Continues West Coast Expansion with Addition of Craig Menden Menden's practice focuses on corporate transactions involving emerging growth companies, has handled more than 100 mergers and acquisitions totaling more than $35 billion plus an impressive array of venture capital transactions.

back

top